Literature DB >> 9834006

Considerations in the attainment of steady state: aggregate vs. individual assessment.

W W Hauck1, T N Tozer, S Anderson, F Y Bois.   

Abstract

Mesh：

Year:  1998        PMID： 9834006     DOI： 10.1023/a:1011933401522

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  4 in total

1.  A distribution-free procedure for the statistical analysis of bioequivalence studies.

Authors:  D Hauschke; V W Steinijans; E Diletti
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-02

2.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

3.  The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results.

Authors:  S N Goodman; J A Berlin
Journal:  Ann Intern Med       Date:  1994-08-01       Impact factor: 25.391

4.  A new statistical procedure for testing equivalence in two-group comparative bioavailability trials.

Authors:  W W Hauck; S Anderson
Journal:  J Pharmacokinet Biopharm       Date:  1984-02
  4 in total
  2 in total

Review 1.  Evaluation of methods for estimating time to steady state with examples from phase 1 studies.

Authors:  Lata Maganti; Deborah L Panebianco; Andrea L Maes
Journal:  AAPS J       Date:  2008-02-28       Impact factor: 4.009

2.  Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml.

Authors:  A Steinstraesser; R Schmidt; K Bergmann; R Dahmen; R H A Becker
Journal:  Diabetes Obes Metab       Date:  2014-03-24       Impact factor: 6.577
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.